Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1944 1
1945 73
1946 233
1947 301
1948 331
1949 297
1950 503
1951 678
1952 753
1953 772
1954 898
1955 943
1956 892
1957 775
1958 691
1959 632
1960 703
1961 752
1962 820
1963 1082
1964 1576
1965 1232
1966 1072
1967 1232
1968 1393
1969 1779
1970 1879
1971 2638
1972 2983
1973 3275
1974 3350
1975 3314
1976 3211
1977 3012
1978 3118
1979 3287
1980 2855
1981 2629
1982 2865
1983 3271
1984 3461
1985 3582
1986 3459
1987 4082
1988 3850
1989 4158
1990 4316
1991 4449
1992 4623
1993 4789
1994 4774
1995 4799
1996 4834
1997 5104
1998 5140
1999 5638
2000 5814
2001 6244
2002 6400
2003 6855
2004 7150
2005 7545
2006 7724
2007 8002
2008 8273
2009 8490
2010 9086
2011 10152
2012 10359
2013 11258
2014 12219
2015 13201
2016 14388
2017 16111
2018 18145
2019 20361
2020 25360
2021 32856
2022 35616
2023 32499
2024 10748

Text availability

Article attribute

Article type

Publication date

Search Results

443,536 results

Results by year

Filters applied: . Clear all
Page 1
Delivery technologies for cancer immunotherapy.
Riley RS, June CH, Langer R, Mitchell MJ. Riley RS, et al. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. Nat Rev Drug Discov. 2019. PMID: 30622344 Free PMC article. Review.
Immunotherapy has become a powerful clinical strategy for treating cancer. The number of immunotherapy drug approvals has been increasing, with numerous treatments in clinical and preclinical development. ...
Immunotherapy has become a powerful clinical strategy for treating cancer. The number of immunotherapy drug approvals has been …
Cancer and the Immune System: The History and Background of Immunotherapy.
Abbott M, Ustoyev Y. Abbott M, et al. Semin Oncol Nurs. 2019 Oct;35(5):150923. doi: 10.1016/j.soncn.2019.08.002. Epub 2019 Sep 13. Semin Oncol Nurs. 2019. PMID: 31526550 Review.
As this knowledge has grown, there has been significant progress in the development of clinically effective cancer immunotherapies. IMPLICATIONS FOR NURSING PRACTICE: Nurses' knowledge of the different types of immunity and the interaction of cancer cells with the immune s …
As this knowledge has grown, there has been significant progress in the development of clinically effective cancer immunotherapies. I …
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications.
Zhang Y, Zhang Z. Zhang Y, et al. Cell Mol Immunol. 2020 Aug;17(8):807-821. doi: 10.1038/s41423-020-0488-6. Epub 2020 Jul 1. Cell Mol Immunol. 2020. PMID: 32612154 Free PMC article. Review.
Immunotherapy has revolutionized cancer treatment and rejuvenated the field of tumor immunology. ...We believe such a review could strengthen our understanding of the progress in cancer immunotherapy, facilitate the elucidation of immune cell modulation in tumor pro …
Immunotherapy has revolutionized cancer treatment and rejuvenated the field of tumor immunology. ...We believe such a review could st …
A review of cancer immunotherapy toxicity.
Kennedy LB, Salama AKS. Kennedy LB, et al. CA Cancer J Clin. 2020 Mar;70(2):86-104. doi: 10.3322/caac.21596. Epub 2020 Jan 16. CA Cancer J Clin. 2020. PMID: 31944278 Free article. Review.
Cancer immunotherapies, including checkpoint inhibitors and adoptive cell therapy, manipulate the immune system to recognize and attack cancer cells. These therapies have the potential to induce durable responses in multiple solid and hematologic malignancies and thus have …
Cancer immunotherapies, including checkpoint inhibitors and adoptive cell therapy, manipulate the immune system to recognize and atta …
Dynamics and specificities of T cells in cancer immunotherapy.
Oliveira G, Wu CJ. Oliveira G, et al. Nat Rev Cancer. 2023 May;23(5):295-316. doi: 10.1038/s41568-023-00560-y. Epub 2023 Apr 12. Nat Rev Cancer. 2023. PMID: 37046001 Free PMC article. Review.
Recent advances in cancer immunotherapy - ranging from immune-checkpoint blockade therapy to adoptive cellular therapy and vaccines - have revolutionized cancer treatment paradigms, yet the variability in clinical responses to these agents has motivated intense interest in …
Recent advances in cancer immunotherapy - ranging from immune-checkpoint blockade therapy to adoptive cellular therapy and vaccines - …
Corticosteroids and Cancer Immunotherapy.
Goodman RS, Johnson DB, Balko JM. Goodman RS, et al. Clin Cancer Res. 2023 Jul 14;29(14):2580-2587. doi: 10.1158/1078-0432.CCR-22-3181. Clin Cancer Res. 2023. PMID: 36648402 Free PMC article. Review.
Despite revolutionizing cancer management, immunotherapies dysregulate the immune system, leading to immune-mediated adverse events. ...While steroids exert several mechanisms to reduce immune activity, immunotherapies, such as immune checkpoint inhibitors (ICI), ar …
Despite revolutionizing cancer management, immunotherapies dysregulate the immune system, leading to immune-mediated adverse events. …
Immunotherapy in soft-tissue sarcoma.
Ayodele O, Razak ARA. Ayodele O, et al. Curr Oncol. 2020 Feb;27(Suppl 1):17-23. doi: 10.3747/co.27.5407. Epub 2020 Feb 1. Curr Oncol. 2020. PMID: 32174754 Free PMC article. Review.
In the advanced setting, the role of systemic therapies is modest and is associated with poor survival. With the discovery of immunotherapies in other tumour types such as melanoma and lung cancer, interest has been renewed in exploring immunotherapy in sts. ...Here …
In the advanced setting, the role of systemic therapies is modest and is associated with poor survival. With the discovery of immunothera …
Integrative Approaches to Cancer Immunotherapy.
Szeto GL, Finley SD. Szeto GL, et al. Trends Cancer. 2019 Jul;5(7):400-410. doi: 10.1016/j.trecan.2019.05.010. Trends Cancer. 2019. PMID: 31311655 Free PMC article. Review.
Cancer immunotherapy aims to arm patients with cancer-fighting immunity. Many new cancer-specific immunotherapeutic drugs have gained approval in the past several years, demonstrating immunotherapy's efficacy and promise as an anticancer modality. Despite the …
Cancer immunotherapy aims to arm patients with cancer-fighting immunity. Many new cancer-specific immunotherapeutic drugs have gained …
Cancer immunoediting and resistance to T cell-based immunotherapy.
O'Donnell JS, Teng MWL, Smyth MJ. O'Donnell JS, et al. Nat Rev Clin Oncol. 2019 Mar;16(3):151-167. doi: 10.1038/s41571-018-0142-8. Nat Rev Clin Oncol. 2019. PMID: 30523282 Review.
Anticancer immunotherapies involving the use of immune-checkpoint inhibitors or adoptive cellular transfer have emerged as new therapeutic pillars within oncology. ...In this Review, we discuss how a deeper understanding of the mechanisms underlying the cancer immunoeditin …
Anticancer immunotherapies involving the use of immune-checkpoint inhibitors or adoptive cellular transfer have emerged as new therap …
TGFbeta biology in cancer progression and immunotherapy.
Derynck R, Turley SJ, Akhurst RJ. Derynck R, et al. Nat Rev Clin Oncol. 2021 Jan;18(1):9-34. doi: 10.1038/s41571-020-0403-1. Epub 2020 Jul 24. Nat Rev Clin Oncol. 2021. PMID: 32710082 Free PMC article. Review.
TGFbeta released by cancer cells, stromal fibroblasts and other cells in the tumour microenvironment further promotes cancer progression by shaping the architecture of the tumour and by suppressing the antitumour activities of immune cells, thus generating an immunosuppressive en …
TGFbeta released by cancer cells, stromal fibroblasts and other cells in the tumour microenvironment further promotes cancer progression by …
443,536 results
You have reached the last available page of results. Please see the User Guide for more information.